The 7.2 mg dose is now given as a single weekly injection, using a dedicated 7.2 mg pen that the MHRA approved in April 2026
Journal of Medical Case Reports: Necrotizing Myopathy and Rhabdomyolysis in a Patient on Tirzepatide - Clinical documentation of rhabdomyolysis associated with tirzepatide use
Rapid weight loss can speed up this process, causing signs of aging to appear faster
Further work showed that GLP-1R-expressing ventral hippocampal neurons are monosynaptically connected to the medial prefrontal cortex (mPFC), and the suppression of food intake and motivated behaviors by intra-ventral hippocampal administration of exendin-4 is lost with their inhibition or antagonism of NMDARs [172]
Clinical trials have shown that after stopping the weight loss medication, patients tend to regain two-thirds of their weight back in one year
Needing your rescue inhaler more and more often can be a sign your asthma is not well controlled, and overusing inhaled rescue medicines has been linked to serious harm